Alnylam Pharmaceuticals (ALNY) Gross Margin Growth (3y) (2021 - 2026)
Alnylam Pharmaceuticals (ALNY) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 193,280.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 589.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 6.06 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 53.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 569.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -21.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.00 |
| Mar 31, 2026 | -480.00 |
| Dec 31, 2025 | -1,062.00 |
| Sep 30, 2025 | -198.00 |
| Jun 30, 2025 | -322.00 |
| Mar 31, 2025 | -81.00 |
| Dec 31, 2024 | -430.00 |
| Sep 30, 2024 | -139.00 |
| Jun 30, 2024 | 352.00 |
| Mar 31, 2024 | 192.00 |
| Dec 31, 2023 | -305.00 |
| Sep 30, 2023 | 596.00 |
| Jun 30, 2023 | -607.00 |
| Mar 31, 2023 | 40.00 |
| Dec 31, 2022 | 321.00 |
| Sep 30, 2022 | -637.00 |
| Jun 30, 2022 | -547.00 |
| Mar 31, 2022 | -95.00 |
| Dec 31, 2021 | -509.00 |
| Sep 30, 2021 | -835.00 |